Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast
- PMID: 18558670
- PMCID: PMC2630425
- DOI: 10.1021/jm800521j
Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast
Abstract
Targeted imaging requires contrast agents that remain in the vasculature for extended periods of time. A new contrast agent is described in which gadolinium is encapsulated within an extremely stable carbon sphere, thus allowing for safe extended residence. Water solubility and small particle size is achieved with novel fullerene chemistry, attaching multiple oligoethylene glycol groups through nitrogen chemistry. These new compounds can be used to visualize tissue architecture in vivo with standard MRI techniques.
Figures


Similar articles
-
Use of trimetasphere metallofullerene MRI contrast agent for the non-invasive longitudinal tracking of stem cells in the lung.Methods. 2016 Apr 15;99:99-111. doi: 10.1016/j.ymeth.2015.11.004. Epub 2015 Nov 10. Methods. 2016. PMID: 26546729 Free PMC article.
-
Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.J Nanosci Nanotechnol. 2010 Dec;10(12):8610-6. doi: 10.1166/jnn.2010.2691. J Nanosci Nanotechnol. 2010. PMID: 21121373 Free PMC article.
-
Gadolinium-containing endohedral fullerenes: structures and function as magnetic resonance imaging (MRI) agents.Dalton Trans. 2014 May 28;43(20):7346-58. doi: 10.1039/c3dt53517g. Dalton Trans. 2014. PMID: 24522668 Review.
-
A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.Invest Radiol. 2013 Nov;48(11):745-54. doi: 10.1097/RLI.0b013e318294de5d. Invest Radiol. 2013. PMID: 23748228
-
Nanotechnology and MRI contrast enhancement.Future Med Chem. 2010 Mar;2(3):491-502. doi: 10.4155/fmc.10.3. Future Med Chem. 2010. PMID: 21426177 Review.
Cited by
-
A platform for specific delivery of lanthanide-scandium mixed-metal cluster fullerenes into target cells.ChemistryOpen. 2012 Oct;1(5):207-10. doi: 10.1002/open.201200023. Epub 2012 Sep 28. ChemistryOpen. 2012. PMID: 24551509 Free PMC article. No abstract available.
-
High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality.Bioconjug Chem. 2010 Apr 21;21(4):610-5. doi: 10.1021/bc900375n. Bioconjug Chem. 2010. PMID: 20218678 Free PMC article.
-
Synthesis of endohedral metallofullerene glycoconjugates by carbene addition.Molecules. 2011 Nov 14;16(11):9495-504. doi: 10.3390/molecules16119495. Molecules. 2011. PMID: 22083236 Free PMC article.
-
Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis.Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7449-54. doi: 10.1073/pnas.0909707107. Epub 2010 Apr 5. Proc Natl Acad Sci U S A. 2010. PMID: 20368438 Free PMC article.
-
Use of trimetasphere metallofullerene MRI contrast agent for the non-invasive longitudinal tracking of stem cells in the lung.Methods. 2016 Apr 15;99:99-111. doi: 10.1016/j.ymeth.2015.11.004. Epub 2015 Nov 10. Methods. 2016. PMID: 26546729 Free PMC article.
References
-
- Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the U.K. and 14 other countries. Lancet. 2004;363:345–351. - PubMed
-
- Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 1996;17:2359–2362. - PubMed
-
- Grobner T. Gadolinium. A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol, Dial, Transplant. 2006;21:1104–1108. - PubMed
-
- Bolskar RD, Benedetto AF, Husebo LO, Price RE, Jackson EF, Wallace S, Wilson LJ, Alford JM. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent. J Am Chem Soc. 2003;125:5471–5478. - PubMed
-
- Mikawa M, Kato H, Okumura M, Narazaki Y, Kanazawa Y, Miwa N, Shinohara H. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem. 2001;12:510–514. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical